AARS2 and mitochondrial disease: Given the increasing influence of targeted exome capture and next generation sequencing to identify novel genes associated with early-onset mitochondrial disease, including several mt-aminoacyl-tRNA synthetases such as AARS2[14] and EARS2[15], our study nicely demonstrates that routine diagnostic genetic testing methodologies including array CGH can be crucial in the identification of underlying genetic defects.